Effect of intravitreal dexamethasone in treatment of pneumococcal endophthalmitis in rabbits.
OBJECTIVE
To investigate whether corticosteroid therapy would decrease the inflammation and tissue damage associated with pneumococcal endophthalmitis.


METHODS
Albino rabbits were injected intravitreally with 1000 live organisms of Streptococcus pneumoniae and randomized after 24 hours to treatment with intravitreal vancomycin hydrochloride alone (n = 10), combination intravitreal vancomycin and intravitreal dexamethasone (n = 10), or no treatment (n = 10). After 2 weeks, the eyes were examined clinically and enucleated for histopathologic examination.


RESULTS
Eyes treated with vancomycin and dexamethasone had significantly less intraocular inflammation and more preservation of retinal tissue than untreated eyes or eyes treated with vancomycin alone (P < .05, Fisher's exact test). Untreated and vancomycin-treated eyes were indistinguishable on clinical and histologic examination. Marked anterior and posterior segment inflammation with total retinal necrosis was noted in eyes from both groups.


CONCLUSIONS
Intravitreal corticosteroid therapy may play an important role in minimizing the inflammation and tissue damage associated with pneumococcal endophthalmitis.
Park
S S
SS
Department of Ophthalmology, University of Texas, Southwestern Medical Center, Dallas, USA.
Samiy
N
N
Ruoff
K
K
D'Amico
D J
DJ
Baker
A S
AS
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D009877:Endophthalmitis / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D015818:Eye Infections, Bacterial / Q000188:drug therapy* / Q000473:pathology; D011008:Pneumococcal Infections / Q000188:drug therapy* / Q000473:pathology; D011817:Rabbits; D011897:Random Allocation; D013296:Streptococcus pneumoniae / Q000187:drug effects / Q000302:isolation & purification; D014640:Vancomycin / Q000627:therapeutic use*; D014822:Vitreous Body / Q000382:microbiology
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D014640:Vancomycin; D003907:Dexamethasone